RF treatment of the duodenum for type 2 diabetes control
Part of Hormones & metabolism clinical trials.
This trial tests whether a procedure that uses heat energy (radiofrequency vapor ablation) applied in the first part of the small intestine (duodenum) can improve blood sugar control in adults with type 2 diabetes. It may help lower blood sugar when standard oral medicines are not keeping it in range.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18–65, and you are a man or a woman who is not pregnant.
- You have type 2 diabetes for at least 3 years but no more than 10 years.
- Your average blood sugar (HbA1c) is between 7.5% and 10%.
- Your body weight is within a BMI range of 24 to 40.
- You take at least one stable diabetes pill (tablet) and haven’t changed diabetes medicine in the last 3 months.
- You can agree to start an additional diabetes medicine (for example, liraglutide) if the study team thinks your sugar stays too high.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether a minimally invasive artery procedure can improve type 2 diabetes and related health problems by targeting kidney and liver blood vessels. Because it’s early-stage, the main goal is safety and learning how the treatment works in people who meet specific diabetes, blood pressure, and blood test requirements.
This Phase 1 study tests a new artery “ablation” procedure for people with type 2 diabetes, aiming to improve diabetes and related conditions like high blood pressure. It will also check whether the procedure is safe and works well enough to study further.
This trial studies whether an endoscopic (camera-guided) stomach tightening/suturing procedure plus standard diabetes care can improve health in people with type 2 diabetes and mild-to-moderate obesity. It compares this procedure to standard care alone to see which approach works better and is safe.
This trial tests a new device that uses radiofrequency energy to treat the lining of the upper small intestine in people with type 2 diabetes. The goal is to see if this treatment is safe and helps improve blood sugar control.
This trial tests a new procedure called pulse electric field ablation to see if it can help people with type 2 diabetes whose blood sugar is not well controlled by oral medications. The procedure uses a small device passed through the mouth to the upper intestine.
This study tests a new procedure called pulsENDO, which is done in the first part of the small intestine (the duodenum) to help treat type 2 diabetes. It may be an option for people who were recently diagnosed and have good blood sugar control with little or no diabetes medication.
Hear when a new Diabetes Mellitus Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.